Ruminococcus gnavus
Selected indexed studies
- Ruminococcus gnavus: friend or foe for human health. (FEMS Microbiol Rev, 2023) [PMID:37015876]
- Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. (Cell Host Microbe, 2023) [PMID:36495868]
- Pueraria lobata-derived exosome-like nanovesicles alleviate rheumatoid arthritis via targeting Ruminococcus gnavus phenylethylamine production. (Gut, 2026) [PMID:41475979]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ruminococcus gnavus: friend or foe for human health. (2023) pubmed
- Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. (2023) pubmed
- Pueraria lobata-derived exosome-like nanovesicles alleviate rheumatoid arthritis via targeting Ruminococcus gnavus phenylethylamine production. (2026) pubmed
- A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. (2017) pubmed
- Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide. (2019) pubmed
- Ruminococcus gnavus in the gut: driver, contributor, or innocent bystander in steatotic liver disease? (2025) pubmed
- Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient. (2023) pubmed
- Microbial genes and pathways in inflammatory bowel disease. (2019) pubmed
- Microbe Profile: Ruminococcus gnavus: the yin and yang of human gut symbionts. (2023) pubmed
- Ruminococcus gnavus and Limosilactobacillus reuteri Regulate Reg3γ Expression through Multiple Pathways. (2023) pubmed